BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18567421)

  • 1. Corticosteroid pulse therapy for leprosy complicated by a severe type 1 reaction.
    Lu PH; Lin JY; Tsai YL; Kuan YZ
    Chang Gung Med J; 2008; 31(2):201-6. PubMed ID: 18567421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
    Rodríguez G; Pinto R; López F; Gómez Y
    Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leprosy type 1 reaction as the first manifestation of borderline lepromatous leprosy in a young native German.
    Biedermann T; Degitz K; Schirren CG; Burgdorf W; Plewig G; Bieber T
    Br J Dermatol; 1997 Dec; 137(6):1006-10. PubMed ID: 9470925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lepromatous leprosy.
    Booth AV; Kovich OI
    Dermatol Online J; 2007 Jan; 13(1):9. PubMed ID: 17511942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of short term results in two multidrug regimens in multibacillary leprosy.
    Singh RP; Tiwari VD; Chattopadhyay SP
    Indian J Lepr; 1993; 65(2):173-80. PubMed ID: 8345231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patient with Hansen disease and lepromatous reaction with predominant neural involvement].
    Gálvez J; López-Domínguez JM; Navarro A; Creagh R; Casado JL; Chinchón Lara I
    Neurologia; 1998 Jan; 13(1):41-4. PubMed ID: 9522583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
    Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
    Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy.
    Jamet P; Blanc L; Fayne OC; Traore I; Bobin P
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):209-14. PubMed ID: 8046259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leprosy in a renal transplant recipient: review of the literature.
    Guditi S; Ram R; Ismal KM; Sahay M; Dakshinamurthy KV; Girish N; Prasad N
    Transpl Infect Dis; 2009 Dec; 11(6):557-62. PubMed ID: 19656347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction.
    Tang ASO; Wong QY; Yeo ST; Ting IPL; Lee JTH; Fam TL; Chew LP; Chua HH; Muniandy P
    Am J Case Rep; 2021 May; 22():e931655. PubMed ID: 34038399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leprosy: recognizing red flags.
    Pearce V; Horton JJ
    Australas J Dermatol; 2008 Nov; 49(4):226-8. PubMed ID: 18855787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline-induced hyperpigmentation in leprosy.
    Fleming CJ; Hunt MJ; Salisbury EL; McCarthy SW; Barnetson RS
    Br J Dermatol; 1996 Apr; 134(4):784-7. PubMed ID: 8733393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo following type II lepra reaction.
    Pavithran K
    Indian J Lepr; 1989 Jan; 61(1):44-8. PubMed ID: 2703744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome-like presentation in borderline leprosy with type-2 reaction.
    Rai VM; Shenoi S; Rao SN
    Dermatol Online J; 2006 Feb; 12(2):21. PubMed ID: 16638414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
    Norman G; Joseph G; Richard J
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):1-7. PubMed ID: 15217321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
    Fajardo TT; Villahermosa L; Pardillo FE; Abalos RM; Burgos J; Dela Cruz E; Gelber RH
    Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant lucio phenomenon and erythema nodosum in a leprosy patient: clues for their distinct pathogeneses.
    Benard G; Sakai-Valente NY; Bianconcini Trindade MA
    Am J Dermatopathol; 2009 May; 31(3):288-92. PubMed ID: 19384072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.